TH124135A - - Google Patents

Info

Publication number
TH124135A
TH124135A TH801005666A TH0801005666A TH124135A TH 124135 A TH124135 A TH 124135A TH 801005666 A TH801005666 A TH 801005666A TH 0801005666 A TH0801005666 A TH 0801005666A TH 124135 A TH124135 A TH 124135A
Authority
TH
Thailand
Prior art keywords
estradiol
lactose
levonorgestrel
pharmaceuticals
beta
Prior art date
Application number
TH801005666A
Other languages
English (en)
Thai (th)
Original Assignee
นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Filing date
Publication date
Application filed by นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ filed Critical นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Publication of TH124135A publication Critical patent/TH124135A/th

Links

TH801005666A 2008-11-03 TH124135A (https=)

Publications (1)

Publication Number Publication Date
TH124135A true TH124135A (https=) 2013-05-31

Family

ID=

Similar Documents

Publication Publication Date Title
Schindler The “newer” progestogens and postmenopausal hormone therapy (HRT)
Junge et al. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study
Africander et al. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception
Sitruk-Ware Hormonal contraception and thrombosis
JP2019163318A5 (https=)
US8349820B2 (en) Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido
Sweeney et al. Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study
AR082998A1 (es) Asociacion farmaceutica para tratar y/o prevenir mioma y/o endometriosis, uso de resveratrol y progestogeno, composicion farmaceutica para tratamiento y/o prevencion de mioma y/o endometriosis, medicamento para tratamiento y/o prevencion de mioma y/o endometriosis, kit y metodo para tratamiento y/o prevencion de mioma y/o endometriosis
ATE493132T1 (de) Arzneimittel umfassend wenigstens ein gestagen
KR970069031A (ko) 당 제피로부터 스테로이드의 방출이 조절되는 약제학적 정제
PE20080273A1 (es) Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico
JP2010508275A5 (https=)
Grandi et al. Pharmacokinetic evaluation of desogestrel as a female contraceptive
NO20022292L (no) Nye topiske östrogenprogestogenpreparater med systemisk effekt
Raps et al. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial
RU2007148080A (ru) Составы и способы для лечения симптомов, связанных с циклом
CA2608639A1 (en) Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate
Guerra et al. Progestins in combined contraceptives
AU2003253506A1 (en) Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
WO2005077968A3 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
JP2008515909A5 (https=)
TH124135A (https=)
Bitzer et al. Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
Bouchard Chlormadinone acetate (CMA) in oral contraception–a new opportunity
Gandhi et al. Evolution of Oral Contraceptive Pills: AB Gandhi and PA Supe